Related Experiment Videos
[Synthesis and teratogenic action of n-hydroxythalidomide].
G Blaschke1, H R Hess, N P Lüpke
1Institu für Pharmazeutische Chemie Toxikologie der Westfálischen Wilhelms-Universität Münster.
Arzneimittel-Forschung
|March 1, 1989
Summary
N-Hydroxythalidomide, a thalidomide metabolite, showed greater teratogenicity in chicken embryos than thalidomide itself. This study investigated the developmental toxicity of these compounds using the Hen's-Egg-Test.
Area of Science:
- Medicinal Chemistry
- Developmental Toxicology
- Pharmacology
Context:
- Thalidomide (1a) is a known teratogen, necessitating the study of its metabolites.
- N-Hydroxythalidomide (1d) is a potential metabolite of thalidomide.
- The Hen's-Egg-Test (HET) is a validated model for assessing teratogenicity.
Purpose:
- To synthesize N-Hydroxythalidomide (1d) from N-phthalyglutaminic acid anhydride (1b).
- To evaluate and compare the teratogenic potential of N-Hydroxythalidomide (1d) and thalidomide (1a) in vivo.
- To assess the teratogenicity of an oxygen-protected precursor, N-hydroxythalidomide (1c).
Summary:
- N-Hydroxythalidomide (1d) was synthesized and tested for teratogenicity using the Hen's-Egg-Test.
- Results indicate N-Hydroxythalidomide (1d) is significantly more teratogenic (28-46% malformations) than thalidomide (1a) (20-23% malformations) in chicken embryos.
- The oxygen-protected precursor (1c) exhibited lower teratogenicity (11-15%).
Impact:
- This research highlights the increased developmental toxicity of a key thalidomide metabolite.
- Findings underscore the importance of evaluating metabolite toxicity in drug safety assessments.
- The study provides crucial data for understanding thalidomide's teratogenic mechanisms and risks.